Insider · CIK 0001422304

Henderson Jane

Reports to the SEC for 8 companies · SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001422304

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-03	APGEApogee Therapeutics, Inc.D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−158K sh	—	—	0
2026-09-03	APGEApogee Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−83.7K sh	—	—	0
2026-09-03	APGEApogee Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−125K sh	—	—	0
2026-09-03	APGEApogee Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−175K sh	—	—	0
2026-07-24	APGEApogee Therapeutics, Inc.G Gift	Chief Financial Officer	GGift	−15K sh	—	—	158,371
2026-05-01	APGEApogee Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−289 sh	$83.16	−$24K	173,371
2026-05-01	APGEApogee Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−900 sh	$82.60	−$74.3K	173,660
2026-05-01	APGEApogee Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−811 sh	$81.02	−$65.7K	174,560
2026-04-16	APGEApogee Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−2,000 sh	$90.00	−$180K	175,371
2026-04-01	APGEApogee Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−900 sh	$84.46	−$76K	178,471
2026-04-01	APGEApogee Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−1,100 sh	$85.46	−$94K	177,371
2026-03-25	APGEApogee Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−2,000 sh	$85.00	−$170K	179,371
2026-03-02	APGEApogee Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−406 sh	$71.66	−$29.1K	181,371
2026-03-02	APGEApogee Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−994 sh	$70.45	−$70K	181,777
2026-03-02	APGEApogee Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−300 sh	$69.43	−$20.8K	182,771
2026-03-02	APGEApogee Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−300 sh	$68.27	−$20.5K	183,071
2026-02-02	APGEApogee Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−100 sh	$66.89	−$6,689	183,371
2026-02-02	APGEApogee Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−1,108 sh	$66.15	−$73.3K	183,471
2026-02-02	APGEApogee Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−792 sh	$65.21	−$51.6K	184,579
2026-01-06	APGEApogee Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−2,000 sh	$80.00	−$160K	185,371
2026-01-02	APGEApogee Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−4,080 sh	$75.20	−$307K	187,371
2026-01-02	APGEApogee Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+83.7K sh	—	—	83,690
2026-01-02	APGEApogee Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−1,920 sh	$74.13	−$142K	191,451
2025-12-19	APGEApogee Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−1,500 sh	$80.00	−$120K	193,371
2025-12-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13K sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13K sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−9,398 sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−26K sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11.8K sh	—	—	0
2025-12-04	APGEApogee Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−1,500 sh	$75.00	−$113K	194,871
2025-11-25	APGEApogee Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−1,500 sh	$70.00	−$105K	196,371
2025-11-14	APGEApogee Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−2,000 sh	$65.00	−$130K	197,871
2025-11-11	APGEApogee Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−1,000 sh	$60.00	−$60K	199,871
2025-08-19	CARGO Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2025-08-12	Akero Therapeutics, Inc.S Sale	Director	SSale	−3,000 sh	$47.46	−$142K	9,398
2025-08-12	Akero Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,000 sh	$7.01	+$21K	12,398
2025-08-12	Akero Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,000 sh	—	—	11,797
2025-06-18	CARGO Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2025-06-03	Akero Therapeutics, Inc.A Award	Director	AAward	+9,398 sh	—	—	9,398
2024-12-09	APGEApogee Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+125K sh	—	—	124,962
2024-08-23	APGEApogee Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−6,000 sh	$48.26	−$290K	200,871
2024-06-08	Akero Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+26K sh	—	—	26,000
2024-06-04	CARGO Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+19.8K sh	—	—	19,785
2024-06-04	CARGO Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+39.4K sh	—	—	39,402
2023-12-18	APGEApogee Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+175K sh	—	—	175,345
2023-07-11	IVERIC bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16K sh	—	—	0
2023-07-11	IVERIC bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16K sh	—	—	0
2023-07-11	IVERIC bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−32K sh	—	—	0

Recent filings

Accepted (ET)
Sep 34
Henderson Jane0001140361-26-035611
SEC(opens sec.gov)
Jul 244
Henderson Jane0001104659-26-086729
SEC(opens sec.gov)
May 44
Henderson Jane0001104659-26-055091
SEC(opens sec.gov)
Apr 174
Henderson Jane0001104659-26-045062
SEC(opens sec.gov)
Apr 34
Henderson Jane0001104659-26-039708
SEC(opens sec.gov)
Mar 274
Henderson Jane0001104659-26-036332
SEC(opens sec.gov)
Mar 44
Henderson Jane0001104659-26-023651
SEC(opens sec.gov)
Feb 44
Henderson Jane0001104659-26-010453
SEC(opens sec.gov)
Jan 64
Henderson Jane0001104659-26-001483
SEC(opens sec.gov)

Companies

Address

C/O APOGEE THERAPEUTICS, INC. 1 LETTERMAN DRIVE, BUILDING B

SAN FRANCISCO, CA, 94129